| 12331039 |
Inhibitors of fibroblast growth factor receptor kinases |
Stephen W. Kaldor, John Tyhonas, Eric A. Murphy, Toufike Kanouni, Robert S. KANIA +1 more |
2025-06-17 |
|
| 12145911 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2024-11-19 |
|
| 11970448 |
Monomers capable of dimerizing in an aqueous solution, and methods of using same |
Francis Barany, Maneesh Pingle, Donald E. Bergstrom, Sarah F. Giardina |
2024-04-30 |
|
| 11814376 |
Hepatitis b core protein modulators |
William W. Turner, Jr., Hans Maag, Leping Li, Mark G. Bures, Simon Nicolas Haydar +1 more |
2023-11-14 |
$1,064,000 |
| 11667634 |
Inhibitors of RAF kinases |
Stephen W. Kaldor, Toufike Kanouni |
2023-06-06 |
$4,094,000 |
| 11524940 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2022-12-13 |
$1,775,000 |
| 11472793 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2022-10-18 |
$2,063,000 |
| 11447493 |
Inhibitors of cyclin-dependent kinases |
Toufike Kanouni, Stephen W. Kaldor, Eric A. Murphy |
2022-09-20 |
|
| 11390618 |
Inhibitors of cyclin-dependent kinases |
Toufike Kanouni, Stephen W. Kaldor, Eric A. Murphy, John Tyhonas |
2022-07-19 |
$9,748,000 |
| 11345681 |
Inhibitors of fibroblast growth factor receptor kinases |
Stephen W. Kaldor, John Tyhonas, Eric A. Murphy, Toufike Kanouni, Robert S. KANIA +1 more |
2022-05-31 |
$5,734,000 |
| 11312704 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2022-04-26 |
$8,020,000 |
| 11174231 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2021-11-16 |
$1,832,000 |
| 11124497 |
Inhibitors of cysteine proteases and methods of use thereof |
Andy Jennings, Walter Keung |
2021-09-21 |
$704,000 |
| 11078170 |
Cyclic sulfamide compounds and methods of using same |
William W. Turner, Jr., Leping Li, Simon Nicolas Haydar, Mark G. Bures, Roopa Rai +1 more |
2021-08-03 |
$3,147,000 |
| 11040965 |
Process for making Hepatitis B core protein modulators |
Leping Li, Sreenivasa Reddy Mundla |
2021-06-22 |
$3,217,000 |
| 10987360 |
Hepatitis B core protein modulators |
William W. Turner, Jr., Leping Li, Mark G. Bures, Simon Nicolas Haydar, Hans Maag +1 more |
2021-04-27 |
$3,545,000 |
| 10968211 |
Hepatitis B core protein modulators |
William W. Turner, Jr., Hans Maag, Leping Li, Mark G. Bures, Simon Nicolas Haydar +1 more |
2021-04-06 |
$3,629,000 |
| 10947224 |
Hepatitis B core protein allosteric modulators |
William W. Turner, Jr., Hans Maag, Adam Zlotnick |
2021-03-16 |
|
| 10927111 |
Inhibitors of RAF kinases |
Stephen W. Kaldor, Toufike Kanouni |
2021-02-23 |
$21,681,000 |
| 10912786 |
Silyl monomers capable of multimerizing in an aqueous solution, and methods of using same |
Francis Barany, Maneesh Pingle, Donald E. Bergstrom, Sarah F. Giardina |
2021-02-09 |
|
| 10894788 |
Inhibitors of cyclin-dependent kinases |
Toufike Kanouni, Stephen W. Kaldor, Eric A. Murphy, John Tyhonas |
2021-01-19 |
$28,381,000 |
| 10392379 |
Hepatitis B core protein modulators |
William W. Turner, Jr., Hans Maag, Mark G. Bures |
2019-08-27 |
$4,461,000 |
| 10377748 |
Hepatitis B core protein modulators |
William W. Turner, Jr., Hans Maag, Leping Li, Mark G. Bures, Simon Nicolas Haydar +1 more |
2019-08-13 |
$4,919,000 |
| 10273228 |
Hepatitis B viral assembly effectors |
Hans Maag, William W. Turner, Jr. |
2019-04-30 |
|
| 10214513 |
Heterocyclic compounds useful for kinase inhibition |
Eric A. Murphy |
2019-02-26 |
|
